Busan, South Korea

Sungmin Kiem

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: MD Healthcare Inc.. Active years: 2019.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Sungmin Kiem in Pathogen Identification

Introduction

Sungmin Kiem is an accomplished inventor based in Busan, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in identifying pathogens responsible for bacterial infectious diseases. His innovative approach utilizes bacteria-derived nanovesicles to enhance the accuracy of clinical predictions.

Latest Patents

Sungmin Kiem holds a patent for a method titled "Method for identifying pathogens of bacterial infectious diseases by using bacteria-derived nanovesicles." This invention focuses on predicting causative factors of serious bacterial infections through the analysis of genes contained in nanovesicles. The method provides crucial information regarding bacterial infections, predicts causative factors, and assesses bacterial resistance to antibiotics.

Career Highlights

Kiem is currently associated with MD Healthcare Inc., where he continues to develop and refine his innovative methodologies. His work has the potential to revolutionize the way bacterial infections are diagnosed and treated, ultimately improving patient outcomes.

Collaborations

Sungmin Kiem collaborates with notable colleagues, including Yoon-Keun Kim and Mina Rho. Their combined expertise contributes to the advancement of research and development in the field of healthcare.

Conclusion

Sungmin Kiem's innovative work in pathogen identification exemplifies the impact of modern technology on medical diagnostics. His contributions are paving the way for more effective treatments and better healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…